The mission of the Harvey L. Neiman Health Policy Institute® is to establish foundational evidence for health policy and radiology practice that promotes the effective and efficient use of health care resources and improves patient care.
Medical imaging accounts for 85% of digital health’s venture capital funding. As funding grows, it is expected that artificial intelligence (AI) products will increase commensurately. The study’s objective is to project the number of new AI products given the statistical association between historical funding and FDA-approved AI products. Full Article
Nicole K. McNabb, BS Eric W. Christensen, PhD Elizabeth Y. Rula, PhD Laura Coombs, PhD Keith Dreyer, DO, PhD Christoph Wald, MD Christopher Treml, MS. 2023. "Projected Growth in FDA-Approved Artificial Intelligence Products Given Venture Capital Funding," Journal of American College of Radiology (JACR)
The Harvey L. Neiman Health Policy Institute is a differentiating asset of the ACR, positioning the College at the forefront in advocacy by contributing the scientific evidence needed to inform health policy. The investment the ACR makes in advancing this mission keeps the College at the forefront of the field Read More